Related Experiment Videos
Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC)
J M Atkinson1, C J Pennington, S W Martin
1Institute of Cancer Therapeutics, University of Bradford, Tumbling Hill Street, Bradford, West Yorkshire, BD7 1DP, UK.
Abstract:
Improved understanding of the involvement of matrix metalloproteinases (MMPs), including membrane-type MMPs (MT-MMPs), in human tumours has potential diagnostic, prognostic and therapeutic implications. We assessed the relationship between MT-MMP expression and clinicopathological parameters in human non-small cell lung cancer (NSCLC) and histologically normal lung tissue by quantitative Real Time PCR (qRT-PCR). All MT-MMPs (MMPs 14-17, 24 and 25) were detected by qRT-PCR with significantly higher MMP-14, -15 and -17 expression observed in tumour relative to normal lung specimens. MMP-16 was undetectable in normal lung but expressed in 8% tumours. MMP-15 demonstrated significant overexpression in adenocarcinomas relative to squamous cell carcinomas and normal lung tissue. MMP-14 mRNA expression strongly correlated to MMP-14 proteolytic activity in preclinical tumour models, indicating that qRT-PCR may predict MMP-14 activity levels in NSCLC. These data suggest that MMP-14, -15 and -17 may be good markers of disease, or therapeutic targets for treatment of human NSCLC.
Insights
Matrix metalloproteinases (MMPs), particularly MMP-14, -15, and -17, are significantly elevated in non-small cell lung cancer (NSCLC). These MMPs show potential as diagnostic markers and therapeutic targets for lung cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs), including membrane-type MMPs (MT-MMPs), play a role in human tumors.
- Understanding MT-MMP involvement in non-small cell lung cancer (NSCLC) has diagnostic, prognostic, and therapeutic potential.
Purpose of the Study:
- To assess the relationship between MT-MMP expression and clinicopathological parameters in human NSCLC.
- To compare MT-MMP expression in NSCLC tumors versus normal lung tissue.
Main Methods:
- Quantitative Real-Time PCR (qRT-PCR) was used to detect MT-MMP expression (MMPs 14-17, 24, 25).
- MT-MMP expression was analyzed in relation to clinicopathological parameters in NSCLC.
- MMP-14 mRNA expression was correlated with proteolytic activity in preclinical models.
Main Results:
- All tested MT-MMPs were detected by qRT-PCR.
- Significantly higher expression of MMP-14, MMP-15, and MMP-17 was observed in NSCLC tumors compared to normal lung tissue.
- MMP-15 was significantly overexpressed in adenocarcinomas versus squamous cell carcinomas and normal lung tissue.
- MMP-16 was undetectable in normal lung but present in 8% of tumors.
- MMP-14 mRNA expression correlated with MMP-14 proteolytic activity, suggesting qRT-PCR can predict MMP-14 activity.
Conclusions:
- MMP-14, MMP-15, and MMP-17 show significantly altered expression in NSCLC.
- These MMPs may serve as valuable biomarkers for NSCLC diagnosis and prognosis.
- MMP-14, MMP-15, and MMP-17 represent potential therapeutic targets for NSCLC treatment.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...